Diseases, Conditions, Syndromes

One in 10 have long-term effects eight months after mild COVID-19

Eight months after mild COVID-19, 1 in 10 people still have at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are ...

Diseases, Conditions, Syndromes

COVID-19 survivors might need just one dose of two-part vaccine

A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai ...

Diseases, Conditions, Syndromes

Pfizer/BioNTech first dose 85% effective after 2-4 weeks: study

The first dose of the Pfizer/BioNTech vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Diseases, Conditions, Syndromes

Infection higher in hospital cleaners than ICU staff: report

Intensive care medics were significantly less likely to have been infected with COVID-19 than cleaners and other healthcare workers in departments deemed lower risk, according to a study of several British hospitals at the ...

page 3 from 40